(Q34609029)

English

Equilibrative nucleoside transporter 1 genotype, cytidine deaminase activity and age predict gemcitabine plasma clearance in patients with solid tumours

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Equilibrative nucleoside transporter 1 genotype, cytidine deaminase activity and age predict gemcitabine plasma clearance in patients with solid tumours (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Milena Gusella

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Felice Pasini

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Caterina Bolzonella

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Silvia Meneghetti

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Carmen Barile

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Antonio Bononi

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Silvia Toso

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Daniela Menon

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Giorgio Crepaldi

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Yasmina Modena

10

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Laura Stievano

11

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Roberto Padrini

12

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

1 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

71

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

437-444

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Clinical pharmacology and pharmacogenetics of gemcitabine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045553

7 July 2018

Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045553

7 July 2018

Prolonged versus standard gemcitabine infusion: translation of molecular pharmacology to new treatment strategy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045553

7 July 2018

Population pharmacokinetics of gemcitabine and its metabolite in patients with cancer: effect of oxaliplatin and infusion rate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045553

7 July 2018

Human equilibrative nucleoside transporter 1 is associated with the chemosensitivity of gemcitabine in human pancreatic adenocarcinoma and biliary tract carcinoma cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045553

7 July 2018

Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045553

7 July 2018

A phase 1 and pharmacokinetic study of gemcitabine and oxaliplatin in patients with solid tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045553

7 July 2018

Severe drug toxicity associated with a single-nucleotide polymorphism of the cytidine deaminase gene in a Japanese cancer patient treated with gemcitabine plus cisplatin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045553

7 July 2018

Determinants of sensitivity and resistance to gemcitabine: the roles of human equilibrative nucleoside transporter 1 and deoxycytidine kinase in non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045553

7 July 2018

Functional and genetic diversity in the concentrative nucleoside transporter, CNT1, in human populations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045553

7 July 2018

Nucleoside transporters in the disposition and targeting of nucleoside analogs in the kidney

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045553

7 July 2018

Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045553

7 July 2018

Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045553

7 July 2018

Differential expression of human nucleoside transporters in normal and tumor tissue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045553

7 July 2018

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045553

7 July 2018

Expression of cytidine deaminase in human solid tumors and its regulation by 1 alpha,25-dihydroxyvitamin D3.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045553

7 July 2018

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045553

7 July 2018

Functional single nucleotide polymorphism haplotypes in the human equilibrative nucleoside transporter 1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2010.03838.X

21 January 2018

Cytidine deaminase in polymyalgia rheumatica and elderly onset rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2010.03838.X

21 January 2018

The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2010.03838.X

21 January 2018

Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2010.03838.X

21 January 2018

Randomized crossover study evaluating the effect of gemcitabine infusion dose rate: evidence of auto-induction of gemcitabine accumulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2010.03838.X

21 January 2018

Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045553

26 October 2018

In situ hybridization and immunolocalization of concentrative and equilibrative nucleoside transporters in the human intestine, liver, kidneys, and placenta

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2010.03838.X

21 January 2018

Gemcitabine in leukemia: a phase I clinical, plasma, and cellular pharmacology study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21284703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kinetic studies on 2',2'-difluorodeoxycytidine (Gemcitabine) with purified human deoxycytidine kinase and cytidine deaminase

1 reference

https://pubmed.ncbi.nlm.nih.gov/21284703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum cytidine deaminase as a measure of disease activity in rheumatoid arthritis and systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/21284703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deoxycytidine kinase and deoxycytidine deaminase activities in human tumour xenografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/21284703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism

1 reference

https://pubmed.ncbi.nlm.nih.gov/21284703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid determination of gemcitabine in plasma and serum using reversed-phase HPLC

1 reference

https://pubmed.ncbi.nlm.nih.gov/21284703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2125.2010.03838.X

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34609029&oldid=1556859399"